# GLRA1

## Overview
The GLRA1 gene encodes the glycine receptor alpha 1 (GlyRα1) subunit, a critical component of the glycine receptor, which is a pentameric ligand-gated ion channel belonging to the Cys-loop receptor family. This receptor plays a pivotal role in inhibitory neurotransmission within the central nervous system by mediating chloride ion influx upon glycine binding, leading to neuronal hyperpolarization and reduced excitability. The GlyRα1 subunit is essential for the formation of functional glycine receptors, which can exist as either homomeric or heteromeric complexes, the latter involving the glycine receptor beta subunit (GlyRβ). These receptors are crucial for maintaining motor control and sensory processing, particularly in the spinal cord and brainstem. Mutations in GLRA1 are linked to hyperekplexia, a neurological disorder characterized by an exaggerated startle reflex, underscoring the gene's clinical significance (Cascio2004Structure; Shiang1995Mutational; Grenningloh1990Alpha).

## Structure
The GLRA1 gene encodes the alpha 1 subunit of the glycine receptor, a pentameric ligand-gated ion channel that is part of the Cys-loop receptor family. The primary structure of the GLRA1 protein consists of a sequence of amino acids that form distinct domains, including an extracellular domain (ECD) and a transmembrane domain (TMD) (Bode2014The). The ECD features a twisted β-sheet sandwich structure, which contains the ligand-binding site, while the TMD is composed of four α-helices (TM1-TM4) (Bode2014The). The TM2 domains line the axial channel pore, playing a crucial role in ion conduction (Bode2014The).

The quaternary structure of the glycine receptor involves the assembly of five subunits, which can form either α homomers or αβ heteromers. In the heteromeric form, the β subunit aids in the attachment to the subsynaptic clustering protein, gephyrin (Bode2014The). The β8-β9 loop within the ECD is a critical structural element, influencing ligand binding and channel gating (Janzen2017The). Mutations in this loop, such as Q177K, can disrupt hydrogen bonding networks, affecting receptor function and synaptic integration (Janzen2017The; Schaefer2017Disruption). Common post-translational modifications of the GLRA1 protein include phosphorylation and glycosylation, which are typical for proteins in this family.

## Function
The GLRA1 gene encodes the alpha 1 subunit of the glycine receptor, a ligand-gated ion channel that plays a crucial role in inhibitory neurotransmission in the central nervous system. This receptor is primarily involved in mediating chloride ion influx upon binding with the neurotransmitter glycine, leading to hyperpolarization of the neuron and reduced neuronal excitability. This process is essential for maintaining proper motor control and sensory processing, particularly in the spinal cord and brainstem (Cascio2004Structure; Grenningloh1990Alpha).

The glycine receptor is a heteropentameric complex, typically composed of alpha and beta subunits, with the alpha 1 subunit being critical for its function. In adults, the most common form of the receptor is a pentameric assembly of α1 and β subunits. The expression of the α1 subunit alone is sufficient to reconstitute native-like glycine receptor activity in heterologous systems, underscoring its importance in receptor function (Cascio2004Structure).

In addition to its role in the central nervous system, the glycine receptor, including the GLRA1 subunit, is expressed in airway smooth muscle, where it modulates muscle contraction. Activation of these receptors by glycine can lead to relaxation of contracted airway smooth muscle, suggesting a potential role in respiratory function (Yim2011Novel).

## Clinical Significance
Mutations in the GLRA1 gene, which encodes the alpha 1 subunit of the glycine receptor, are associated with hyperekplexia, also known as startle disease. This neurological disorder is characterized by an exaggerated startle reflex and muscle stiffness. Hyperekplexia can be inherited in both autosomal dominant and recessive forms. Dominant mutations include R271Q, R271L, and P250T, which affect the receptor's chloride channel gating and glycine-binding affinity, leading to the symptoms of hyperekplexia (Shiang1995Mutational; Saul1999NovelGLRA1Missense). Recessive mutations, such as R100H and Ile244Asn, have also been identified, with affected individuals often being homozygous for these mutations (Coto2005Recessive; Rees1994Evidence).

The clinical presentation of hyperekplexia includes neonatal hypertonia, excessive startle responses, and nocturnal myoclonic jerks. In some cases, mutations in GLRA1 can lead to atypical phenotypes, such as the arginine271proline mutation, which results in progressively severe symptoms (Gregory2008A). Treatment with clonazepam has been shown to alleviate symptoms in some patients (Vergouwe1999Hyperekplexia). The genetic heterogeneity of hyperekplexia suggests that variations in clinical phenotypes may be due to differences in genetic penetrance and background genes (Saul1999NovelGLRA1Missense).

## Interactions
The GLRA1 gene encodes the glycine receptor α1 subunit, which is a critical component of the glycine receptor (GlyR) complex, a pentameric ligand-gated chloride channel involved in inhibitory neurotransmission. The GlyR α1 subunit interacts with the glycine receptor β subunit (GlyRβ) to form heteromeric receptor complexes at synapses. These complexes are anchored to the cytoskeleton by the scaffolding protein gephyrin, which plays a crucial role in synaptic localization and receptor clustering (Wiessler2023Role).

Mutations in GLRA1, such as the Q177K mutation, can disrupt these interactions, leading to impaired glycinergic transmission and neuromotor symptoms associated with startle disease. The Q177K mutation affects the structural integrity of the GlyR α1 subunit, altering its interaction with glycine and reducing the receptor's sensitivity to agonists (Schaefer2017Disruption). Despite these disruptions, the presence of GlyRβ can still facilitate the transport of functionally impaired GlyRα1 variants to synaptic sites, although the effectiveness of these heteromeric complexes is reduced (Wiessler2023Role). The interaction between GlyR α1 and gephyrin is also crucial for proper synaptic function, as evidenced by altered synaptic localization in the presence of the Q177K mutation (Schaefer2017Disruption).


## References


[1. (Coto2005Recessive) Eliecer Coto, Daniel Armenta, Raúl Espinosa, Joaquín Argente, Mónica G. Castro, and Victoria Alvarez. Recessive hyperekplexia due to a new mutation (r100h) in the glra1 gene. Movement Disorders, 20(12):1626–1629, August 2005. URL: http://dx.doi.org/10.1002/mds.20637, doi:10.1002/mds.20637. This article has 15 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1002/mds.20637)

[2. (Rees1994Evidence) Mark I. Rees, Martin Andrew, Sudad Jawad, and Michael J. Owen. Evidence for recessive as well as dominant forms of startle disease (hyperekplexia) caused by mutations in the α1 subunit of the inhibitory glycine receptor. Human Molecular Genetics, 3(12):2175–2179, 1994. URL: http://dx.doi.org/10.1093/hmg/3.12.2175, doi:10.1093/hmg/3.12.2175. This article has 113 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1093/hmg/3.12.2175)

[3. (Shiang1995Mutational) Rita Shiang, Stephen G. Ryan, Ya‐Zhen Zhu, Thomas J. Fielder, Richard J. Allen, Alan Fryer, Sumimasa Yamashita, Peter O’Connell, and John J. Wasmuth. Mutational analysis of familial and sporadic hyperekplexia. Annals of Neurology, 38(1):85–91, July 1995. URL: http://dx.doi.org/10.1002/ana.410380115, doi:10.1002/ana.410380115. This article has 103 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1002/ana.410380115)

[4. (Wiessler2023Role) Anna-Lena Wiessler, Ann-Sofie Hasenmüller, Isabell Fuhl, Clémence Mille, Orlando Cortes Campo, Nicola Reinhard, Joachim Schenk, Katrin G. Heinze, Natascha Schaefer, Christian G. Specht, and Carmen Villmann. Role of the glycine receptor β subunit in synaptic localization and pathogenicity in severe startle disease. The Journal of Neuroscience, 44(2):e0837232023, November 2023. URL: http://dx.doi.org/10.1523/jneurosci.0837-23.2023, doi:10.1523/jneurosci.0837-23.2023. This article has 0 citations.](https://doi.org/10.1523/jneurosci.0837-23.2023)

[5. (Vergouwe1999Hyperekplexia) M. N. Vergouwe, M. A. J. Tijssen, A. C. B. Peters, R. Wielaard, and R. R. Frants. Hyperekplexia phenotype due to compound heterozygosity for glra1 gene mutations. Annals of Neurology, 46(4):634–638, October 1999. URL: http://dx.doi.org/10.1002/1531-8249(199910)46:4<634::aid-ana12>3.0.co;2-9, doi:10.1002/1531-8249(199910)46:4<634::aid-ana12>3.0.co;2-9. This article has 53 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1002/1531-8249(199910)46:4)

[6. (Grenningloh1990Alpha) G. Grenningloh, V. Schmieden, P.R. Schofield, P.H. Seeburg, T. Siddique, T.K. Mohandas, C.M. Becker, and H. Betz. Alpha subunit variants of the human glycine receptor: primary structures, functional expression and chromosomal localization of the corresponding genes. The EMBO Journal, 9(3):771–776, March 1990. URL: http://dx.doi.org/10.1002/j.1460-2075.1990.tb08172.x, doi:10.1002/j.1460-2075.1990.tb08172.x. This article has 206 citations.](https://doi.org/10.1002/j.1460-2075.1990.tb08172.x)

[7. (Yim2011Novel) Peter D. Yim, George Gallos, Dingbang Xu, Yi Zhang, and Charles W. Emala. Novel expression of a functional glycine receptor chloride channel that attenuates contraction in airway smooth muscle. The FASEB Journal, 25(5):1706–1717, January 2011. URL: http://dx.doi.org/10.1096/fj.10-170530, doi:10.1096/fj.10-170530. This article has 28 citations.](https://doi.org/10.1096/fj.10-170530)

[8. (Schaefer2017Disruption) Natascha Schaefer, Alexandra Berger, Johannes van Brederode, Fang Zheng, Yan Zhang, Sophie Leacock, Laura Littau, Sibylle Jablonka, Sony Malhotra, Maya Topf, Friederike Winter, Daria Davydova, Joseph W. Lynch, Christopher J. Paige, Christian Alzheimer, Robert J. Harvey, and Carmen Villmann. Disruption of a structurally important extracellular element in the glycine receptor leads to decreased synaptic integration and signaling resulting in severe startle disease. The Journal of Neuroscience, 37(33):7948–7961, July 2017. URL: http://dx.doi.org/10.1523/JNEUROSCI.0009-17.2017, doi:10.1523/jneurosci.0009-17.2017. This article has 23 citations.](https://doi.org/10.1523/JNEUROSCI.0009-17.2017)

[9. (Saul1999NovelGLRA1Missense) Brigitta Saul, Thomas Kuner, Diana Sobetzko, Wolfram Brune, Folker Hanefeld, Hans-Michael Meinck, and Cord-Michael Becker. Novelglra1missense mutation (p250t) in dominant hyperekplexia defines an intracellular determinant of glycine receptor channel gating. The Journal of Neuroscience, 19(3):869–877, February 1999. URL: http://dx.doi.org/10.1523/jneurosci.19-03-00869.1999, doi:10.1523/jneurosci.19-03-00869.1999. This article has 91 citations.](https://doi.org/10.1523/jneurosci.19-03-00869.1999)

[10. (Bode2014The) Anna Bode and Joseph W Lynch. The impact of human hyperekplexia mutations on glycine receptor structure and function. Molecular Brain, 7(1):2, 2014. URL: http://dx.doi.org/10.1186/1756-6606-7-2, doi:10.1186/1756-6606-7-2. This article has 113 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/1756-6606-7-2)

[11. (Janzen2017The) Dieter Janzen, Natascha Schaefer, Carolyn Delto, Hermann Schindelin, and Carmen Villmann. The glyr extracellular β8–β9 loop – a functional determinant of agonist potency. Frontiers in Molecular Neuroscience, October 2017. URL: http://dx.doi.org/10.3389/fnmol.2017.00322, doi:10.3389/fnmol.2017.00322. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fnmol.2017.00322)

[12. (Gregory2008A) Mary L. Gregory, Greg F. Guzauskas, Terence S. Edgar, Kate B. Clarkson, Anand K. Srivastava, and Kenton R. Holden. A novel glra1 mutation associated with an atypical hyperekplexia phenotype. Journal of Child Neurology, 23(12):1433–1438, September 2008. URL: http://dx.doi.org/10.1177/0883073808320754, doi:10.1177/0883073808320754. This article has 14 citations and is from a peer-reviewed journal.](https://doi.org/10.1177/0883073808320754)

[13. (Cascio2004Structure) Michael Cascio. Structure and function of the glycine receptor and related nicotinicoid receptors. Journal of Biological Chemistry, 279(19):19383–19386, May 2004. URL: http://dx.doi.org/10.1074/JBC.R300035200, doi:10.1074/jbc.r300035200. This article has 134 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/JBC.R300035200)